Jumpstart Ventures

Centerline Biomedical, Inc. is a Cleveland-based company founded in 2014, focused on developing advanced navigation systems for interventional vascular procedures. The company specializes in a non-x-ray based, three-dimensional GPS surgical navigation technology that enhances the precision and outcomes of endovascular procedures while significantly reducing radiation exposure for both patients and healthcare providers. This innovative system assists surgeons in accurately navigating catheters and guide wires through the complex three-dimensional anatomy of patients with vascular diseases, ultimately enabling safer and more effective image-guided surgeries. The technology is rooted in research and development from the Cleveland Clinic, highlighting its commitment to improving surgical practices in the medical field.

Felux is a business-to-business marketplace that focuses on the steel and aluminum industries. The platform provides a comprehensive solution for sourcing, procurement, shipping, financing, and analyzing steel transactions, all in one location. This allows suppliers to digitize their sales and distribution processes, enhancing efficiency in the supply chain. By streamlining these operations, Felux aims to facilitate commerce for all participants in the industrial sector, making it easier for businesses to navigate the complexities of metal transactions.

My One Medical Source (MOMS) is a health-tech company that specializes in connecting diagnostic clinical laboratories with medically-trained personnel for the collection and shipping of specimens. Through its web-based platform, MOMS facilitates interactions between advanced diagnostic labs, patients, and employers seeking skilled labor for lab test collections. The platform supports a national network that includes urgent care centers and mobile phlebotomy providers, enhancing convenient access to necessary lab collection services. By streamlining the process, MOMS aims to provide users with more efficient and accessible solutions for their diagnostic testing needs.

Thrivable is a technology platform that helps health care organizations tap into a comprehensive patient database to do market research activities. Right now the market research process is slow, expensive, and frustrating for companies. Thrivable has created a solution that reduces the time it takes to get insights from months to hours.

Thermalin Diabetes, LLC is a biotechnology company based in Cleveland, Ohio, with an additional office in Newton, Massachusetts. Founded in 2010, the company specializes in developing insulin analogs for the treatment of Type 1 and Type 2 diabetes. Its product offerings include ultra-rapid acting insulin designed to be administered before meals to mitigate glucose spikes, as well as long-acting insulin to maintain basal glucose levels. Thermalin aims to innovate within the insulin market by introducing a highly concentrated, stabilized ultra-rapid acting insulin that can be used in a disposable glucose management system. This new insulin formulation also facilitates the factory-filling of reservoirs for existing insulin pumps. Additionally, the company is exploring partnerships to develop no-cold-chain basal and mixed insulins, as well as glucose-responsive insulins, to enhance patient compliance and treatment outcomes.